AZD9291, an Irreversible EGFR TKI, Overcomes T790M-Mediated Resistance to EGFR Inhibitors in Lung Cancer-Reference-Cited by-同舟云学术

AZD9291, an Irreversible EGFR TKI, Overcomes T790M-Mediated Resistance to EGFR Inhibitors in Lung Cancer

Published:2014-06-03 Issue:9 Volume:4 Page:1046-1061
ISSN:2159-8274
Container-title:Cancer Discovery
language:en
Short-container-title:Cancer Discovery

Author:

Cross Darren A.E.,Ashton Susan E.,Ghiorghiu Serban,Eberlein Cath,Nebhan Caroline A.,Spitzler Paula J.,Orme Jonathon P.,Finlay M. Raymond V.,Ward Richard A.,Mellor Martine J.,Hughes Gareth,Rahi Amar,Jacobs Vivien N.,Brewer Monica Red,Ichihara Eiki,Sun Jing,Jin Hailing,Ballard Peter,Al-Kadhimi Katherine,Rowlinson Rachel,Klinowska Teresa,Richmond Graham H.P.,Cantarini Mireille,Kim Dong-Wan,Ranson Malcolm R.,Pao William

Publisher

American Association for Cancer Research (AACR)

Subject

Oncology

Cited by 1744 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Design, synthesis, and biological evaluation of diphenyl ether substituted quinazolin-4-amine derivatives as potent EGFRL858R/T790M/C797S inhibitors;European Journal of Medicinal Chemistry;2024-12

2. Conserved gatekeeper methionine regulates the binding and access of kinase inhibitors to ATP sites of MAP2K1, 4, and 7: Clues for developing selective inhibitors;Bioorganic & Medicinal Chemistry Letters;2024-11

3. Novel EGFR inhibitors against resistant L858R/T790M/C797S mutant for intervention of non-small cell lung cancer;European Journal of Medicinal Chemistry;2024-11

4. Taxus chinensis var. mairei (Lemée et Lévl) Cheng et L.K. Fu overcomes the resistance to osimertinib in EGFR-mutant non-small-cell lung cancer via suppression of ERK1/2-related cholesterol biosynthesis;Journal of Ethnopharmacology;2024-11

5. Targeting EGFR by Newer 1-(3,5-Bis((E)-4‑hydroxy-3-methoxystyryl)-1H-pyrazol-1-yl)-2-((substituted phenyl)amino)ethan-1-one Analogues for the Treatment of Cancer: Synthesis, In-vitro and In-silico Studies;Journal of Molecular Structure;2024-11